The primary goal of the 9th AMIT Congress, following its own tradition, is to update the health care workers on clinical and therapeutic management of infectious diseases due to multidrug-resistant bacteria (MDR) and viruses.
The last three years have been characterized by SARS-CoV-2 pandemic At present, it is unthinkable to declare the COVID era over despite there having been key changes since the beginning of the pandemic until the present day.
We have learned a lot in this period about evolution and knowledge of the SARSCoV- 2 virus. A better management of prevention and therapeutic approaches have been set up.
SARS-CoV-2 pandemic focused our attention from 2020 but unfortunately other infections have not disappeared at all. In the same period MDR infections have increased both in hospital and community settings causing millions of deaths all over the world. MDR infections have been called a “silent pandemic” because very little is known by population and underrepresented by media. Frail and immunocompromised patients, mostly if they have been infected by SARS-CoV-2, have higher risk factors for getting often, life threatening MDR infections. HIV infection is not defeated and other new epidemics have emerged through an intricate and complex biological process known as “spillover” i.e. the passage of pathogenic microorganisms from animals to humans.
A striking example occurred, fortunately limited, with Monkeypox infections which reminded us of the past scourge of smallpox declared eradicated by the WHO in 1980. For these reasons both at present and in the near future we cannot exclude emerging or re-emerging pathologies due to “spillover”.
International and national institutions (WHO, CDC, ECDC, ISS) will have increasingly to face not only current pandemics (SARS-CoV-2, MDR, HIV, etc.) but also need to prevent incoming potential serious risks for the population by globally shared rapid alert mechanisms and response models.
The AMIT Congress will consider all the mentioned risks of infections through presentations given by a leading panel of infectious diseases specialists and scientists. The most innovative therapeutic tools for eradicating infections such as gene therapy, new preventive strategies for vaccination and incoming therapeutic approaches both for bacterial and viral infections will be the main topics of the Congress.
The 9th AMIT Congress is once again committed to giving the best contribution of knowledge to clinicians to ensure the best quality of life for patients and the population.